Articles tagged with Dna Methylation
Researchers found that DNA methylation changes occurring early in life may have lasting impacts on a child's health. The study also showed that maternal factors like BMI prior to pregnancy can lead to molecular changes on an epigenetic level, persisting into childhood.
Researchers have discovered that adenosine therapy can reduce seizures and slow the progression of epilepsy by targeting epigenetic changes in the brain. By delivering adenosine directly to the brain, scientists were able to reverse DNA hypermethylation, which is a key factor in the development of epilepsy.
A new study by Salk scientists reveals that the landscape of DNA methylation in brain cells is highly dynamic during brain circuitry formation, helping to understand how information in the genome is controlled from fetal development to adulthood. The discovery opens a deeper understanding of how intricate patterns of connectivity in th...
Researchers discovered unique patterns of DNA methylation that emerge when neurons form new connections in children's developing brains, shedding light on the role of epigenomics in learning, memory, and mental illness. The study provides a new framework for understanding brain development and function.
Researchers discovered significant brain epigenome changes from birth to adolescence, transforming the frontal cortex and shaping communication spaces between neurons. The study's findings have profound implications for understanding brain biology and potentially treating neurodevelopmental disorders like autism and schizophrenia.
A large research team elucidated how precise chemical modifications across the genome turn genes on and off during early human development. The study found that master genes governing development are silenced by histone methylation, while genes orchestrating cellular differentiation are primarily silenced by DNA methylation.
Researchers found that weight loss after gastric bypass surgery changes DNA methylation, affecting genes controlling glucose and fat metabolism. This reversal coincides with weight loss and improvement in overall metabolic health.
Researchers have discovered that 37% of the placental genome has regions of lower methylation, called partially methylated domains (PMDs), where gene expression is turned off. This could enhance our understanding of epigenetics and its impact on human development, cancer research and autism.
Researchers have identified the LY86 gene as a key contributor to obesity, finding high methylation levels associated with increased inflammation and insulin resistance. This association held up across various populations, suggesting a potential link between environmental factors and genetic expression.
A new study by Lund University researchers has found that epigenetic changes, such as DNA methylation, can influence the function of insulin-producing cells and alter genetic risk variants for type 2 diabetes. The findings suggest that these modifications may play a key role in the development of the disease.
Researchers have created a single-molecule test for detecting methylated DNA, eliminating the need for current processes like bisulfite conversion and polymerase chain reaction. This assay could be a valuable tool for differentiating methylated from non-methylated DNA in cancer research.
Researchers found that DNA methylation levels were higher in genes associated with disease in children conceived during periods of food scarcity in West Africa.
Researchers discovered that plant epigenomes are as varied as the environments in which they grow, enabling rapid adaptation. This knowledge may aid in crop production and the study of human diseases.
Researchers at BUSM propose a new epigenetic hypothesis linked to tumor production and suggest epigenetic drug treatments could be beneficial in treating cancers. They explore the role of DNA methylation and demethylation enzymes in regulating gene expression, suggesting potential therapeutic targets.
A new study from Duke University Medical Center suggests that a father's obesity may alter a genetic mechanism in the next generation, potentially raising the risk for diseases like cancer. Researchers found that paternal obesity was associated with lower DNA methylation at the IGF2 gene in offspring.
A study published in BMC Medicine found that newborns of obese fathers have lower DNA methylation levels of the IGF2 gene, which codes for a growth factor important during fetal development. This can lead to increased cancer risk later in life.
Research identifies epigenetic changes in Hutchinson-Gilford Progeria and Werner Syndrome patients, revealing a potential role for DNA methylation in premature aging diseases. No genetic cause has been previously associated with the onset of these conditions.
Researchers found three distinct subtypes of non-Hodgkin's lymphoma, each more aggressive than the next, with varying levels of abnormal DNA methylation. This study suggests that epigenomic abnormalities play a significant role in cancer development and progression.
Researchers found a significant link between herbivore activity, phenotypic plasticity, and epigenetic changes in European holly. The study suggests that plants can quickly respond to environmental changes through epigenetic modifications, making them more resilient.
A study found that age drives molecular changes in genes, but diet can modulate these effects. Selenium and vitamin D reduced accumulation of epigenetic changes, while high blood folate and obesity increased them.
A NIH study found that changes in immune gene function may cause age-related macular degeneration (AMD). Decreased DNA methylation led to increased IL17RC protein, promoting inflammation and immune cell recruitment that damages the retina.
A University of British Columbia study reveals that childhood poverty and stress as an adult leave imprints on genes and predict future immune responses. The research found correlations between DNA methylation patterns and early life experiences.
A Simon Fraser University physicist has discovered a link between variable methylation in DNA and various attributes such as age, gender, stress, and socioeconomic status. The study found that childhood poverty left a detectable molecular mark on an individual's DNA, which correlated with gene expression.
Researchers from the University of North Carolina School have established a connection between histone H3 lysine 9 methylation and DNA methylation, implicating protein UHRF1 in their maintenance. This finding may provide clues to the underlying causes of disease and cancer.
Dr. Timothy Bestor's research could overturn a 20-year-old theory of carcinogenesis, instead proposing that methylation changes kill incipient cancer cells. The study aims to develop new methods to differentiate between 'driver' and 'passenger' epigenetic events in tumor development.
Recent research in epigenetics has identified two key tests that can predict brain tumor sensitivity to temozolomide and distinguish prostate cancer from benign growth. New epigenetic biomarkers are being rapidly developed to predict treatment performance and weaknesses of tumors.
Researchers found that fusion-negative prostate cancers have different DNA methylation patterns than healthy cells, with increased EZH2 enzyme activity. This discovery may lead to more specific treatments and improved diagnosis for prostate cancer patients.
A Thomas Jefferson University team found that histone-modifying proteins, such as TrxG and PcG, remain attached to DNA after replication, rather than histones. This challenges the longstanding paradigm of epigenetic marks and has significant implications for understanding gene expression and disease mechanisms.
Researchers found that DNA methylation modifications may contribute to phenotypic changes in humans and chimps. The study suggests that methylation differences between the species might be linked to human disease vulnerability.
New study reveals that genetic variations in DNA methylation patterns contribute to human susceptibility to cancer and other diseases. Researchers found hundreds of genes with distinct methylation profiles, many linked to specific human diseases.
Researchers mapped ant genomes to reveal relationship between epigenetic regulation and caste differentiation. DNA methylation patterns correlated with alternative splicing events and caste-specific genes.
Researchers at Ruhr-University Bochum found that acute stress increases DNA methylation of the oxytocin receptor gene, leading to excessive receptor production. This change may contribute to the development of chronic diseases such as cancer or depression.
Scientists discovered that exposure to pathogens causes significant changes in a plant's epigenetic code, which helps the plant develop resistance. These epigenetic changes are linked to genes responsible for coordinating stress responses, suggesting the epigenome plays a role in disease resistance.
Research found epigenetic changes, specifically DNA methylation, alter genes contributing to rheumatoid arthritis (RA) inflammation and joint damage. RA fibroblast-like synoviocytes display a unique DNA methylome signature compared to normal FLS.
Researchers identify DNA methylation profiles as potential biomarkers for detecting prostate cancer months earlier than current methods. The discovery also predicts recurrence risk and identifies genes that can be targeted with new drugs.
A new study by Karolinska Institutet researchers found that DNA methylation levels in white blood cells are lower in patients with schizophrenia and related to age of disease onset and treatment response. The discovery may lead to the development of a simple test to diagnose schizophrenia.
Researchers at UC Davis found that R-loops prevent methylation at CG island promoters, which are essential for 60% of human genes. This breakthrough could lead to treatments for autoimmune diseases by reversing cytosine methylation.
Researchers at Oregon State University have discovered two epigenetic mechanisms by which sulforaphane prevents cancer: HDAC inhibition and DNA methylation. These mechanisms work together to maintain proper cell function and prevent cancer.
A team of scientists led by Bing Ren has discovered how differential DNA methylation in the parental genomes sets the stage for selective expression of imprinted genes. The study found parent-of-origin specific DNA methylation imprints at 1,952 dinucleotide sequences, including previously unknown regions.
A new NIH study reveals that certain genes implicated in schizophrenia and autism show increased regulatory activity during a critical period of development, influenced by environmental factors. This discovery highlights the importance of epigenetic mechanisms like DNA methylation in shaping brain function and behavior.
A research team led by Prof. Dr. Wolfgang Linke has discovered that protein networks play a crucial role in stabilizing muscle fibers using the same mechanism as DNA methylation. The study found that disrupting this network leads to significant changes in muscle structure and function.
Researchers at University of Cambridge have mapped DNA methylation in human heart, revealing its connection to environmental factors such as diet and lifestyle. The study provides new insights into the genetic changes that can lead to heart disease and potential ways to identify and treat it.
Researchers found evidence of large-scale dynamic DNA demethylation in non-dividing brain cells, challenging scientific dogma. This discovery has major implications for understanding learning, memory, and mood regulation, as well as potential new treatments for depression and neurodegenerative disorders.
A study by CSHL and USC researchers reveals that methylation patterns are dynamic and can influence cell fate. The team observed that subtle changes in methylation within specific regions can lead to the activation of genes associated with particular cell types, challenging traditional views on epigenetics.
Scientists discovered that epigenetic modifications in plants, such as DNA methylation, are unstable and often disappear after a few generations. These changes can occur frequently but usually do not contribute significantly to long-term evolution.
Researchers at Salk Institute discover a "hidden" code linked to DNA that allows plants to develop and pass down new biological traits rapidly. The epigenetic code is found to evolve more quickly than the genetic code and strongly influence biological traits.
A UBC study found that parents' stress during their child's early years can leave lasting marks on their genes, affecting behavior and health in adolescence. Higher stress levels reported by mothers and fathers correlated with specific DNA methylation sites, including those involved in insulin production and brain development.
Research suggests maternal smoking during pregnancy may alter DNA methylation levels in the AXL gene, associated with increased asthma risk in children. The study found a stronger association between maternal smoking and DNA methylation in girls than boys.
Researchers found that a small RNA pathway is required to establish DNA methylation, a process that silences genes. This discovery may lead to new therapies for cancer and other diseases by reactivating silenced tumor-suppressor genes.
Researchers have identified two major sub-types of breast cancer based on DNA methylation profiles, which could help refine cancer classification and predict treatment response. The study also revealed new information about sub-types of breast cancer and the potential for epigenetic therapy.
Researchers identified a step-by-step process involving TET1 and Apobec1 that converts methylated cytosine into hydroxymethylated cytosine, indicating a potential unified mechanism for DNA methylation status change. The discovery has implications for understanding diseases associated with epigenetic abnormality.
Research suggests that specific genes are silenced by DNA methylating enzyme Dnmt3b, similar to those found in human tumors. This targeted silencing may be an initiating event in cancer development.
A new study reveals a previously unrecognized link between tobacco smoking and altered DNA methylation of the coagulation factor II receptor-like 3 (F2RL3) gene, possibly identifying an early stage of smoking-associated cardiovascular pathology.
Scientists found reprogramming errors in iPS cells, including a common defect near telomeres and centromeres. These hotspots resist non-CG methylation, but CG islands are affected, potentially limiting the fate of iPS cells.
A new study reveals that a biomarker test for DNA methylation is technically feasible and could aid in earlier and more precise diagnosis of melanoma. The test distinguishes malignant melanomas from non-malignant moles, with high predictive value.
A new study links an oncometabolite to widespread gene expression alterations in brain cancer and leukemia, promoting tumorigenesis. The research suggests that targeting the metabolic pathway may guide the development of new cancer therapies.
A new research paper published in the Journal of the National Cancer Institute reveals a genetic mutation that leads to abnormal metabolic processes in gliomas, potentially leading to targeted therapies. The study shows that almost all tumors with IDH mutations have the same methylation pattern.
Researchers developed a method to label and map the sixth nucleotide, 5-hydroxymethylcytosine (5-hmC), which is enriched on active genes. The method reveals its genome-wide distribution and functional significance in gene regulation and neurodegeneration.
Researchers trap and observe intermediate stage of DNA repair protein Al McBiotically theft, a process that regulates health conditions such as obesity, cancer, and diabetes. The study provides new insights into how proteins chemically alter biological molecules via oxidative demethylation.
The study sequenced the human methylome from peripheral blood mononuclear cells, identifying allele-specific methylation differences associated with gene expression. The findings suggest that parental gene imprinting may be more common than previously thought, with implications for understanding human health and disease.